When Is It Appropriate to Publish a Meta-Analysis in Cardiovascular Drugs and Therapy?

Charles Maynard; Salim Virani; Hani Jneid; Yochai Birnbaum

doi:10.1007/s10557-023-07445-0

When Is It Appropriate to Publish a Meta-Analysis in Cardiovascular Drugs and Therapy?

Charles Maynard, Salim Virani, Hani Jneid, Yochai Birnbaum

Cardiovascular Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	599-601
Number of pages	3
Journal	Cardiovascular Drugs and Therapy
Volume	37
Issue number	3
DOIs	https://doi.org/10.1007/s10557-023-07445-0
State	Published - Jun 2023

ASJC Scopus subject areas

Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Access to Document

10.1007/s10557-023-07445-0

Cite this

@article{622c8a5583e74588ab7abb6d2364bd0f,

title = "When Is It Appropriate to Publish a Meta-Analysis in Cardiovascular Drugs and Therapy?",

author = "Charles Maynard and Salim Virani and Hani Jneid and Yochai Birnbaum",

year = "2023",

month = jun,

doi = "10.1007/s10557-023-07445-0",

language = "English (US)",

volume = "37",

pages = "599--601",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",